Compared with the non-NAFLD group, the NAFLD group had a higher male/female ratio, BW, BMI, WC, HC, WHR, SBP, DBP, FBG, WBC, NEU, HGB, PLT, ALT, AST, TP, ALB, GGT, ALP, UA, CREA, TC, TG, LDL, HCY, and FLI (all p < 0.05) but lower AST/ALT, DBIL, eGFR, and HDL-C (all p < 0.05). This evidence concerns the gene ALB and metabolic dysfunction-associated steatotic liver disease.